๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Unresectable

SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer๏ผˆSPARKLE๏ผ‰ NCT06767007Phase 21 site๐Ÿ“ Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University ยท Tests: Stereotactic Body Radiation Therapy (SBRT), PD1, Chemotherapy Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors NCT06835387Phase 27 sites๐Ÿ“ Tampa๐Ÿ“ Chicago๐Ÿ“ Fort Wayne Tiago Biachi de Castria ยท Tests: Nanoliposomal irinotecan, Oxaliplatin, 5 fluorouracil, Leucovorin Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003) NCT06561399n/a4 sites๐Ÿ“ Fuzhou๐Ÿ“ Fuzhou๐Ÿ“ Fuzhou Fujian Provincial Hospital ยท Tests: TACE, Lenvatinib combination with Sintilimab sequential radiotherapy Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients NCT06634199n/a22 sites๐Ÿ“ Ferrol๐Ÿ“ Alicante๐Ÿ“ Badalona Fundaciรณn GECP ยท Tests: Durvalumab Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC NCT07500220Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-G3B7-NK dual-target CAR-NK cells, Fludarabine, Cyclophosphamide The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma NCT07645690EARLY Phase 13 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: CLEAR CAR-T cell injection A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma NCT06261359Phase 21 site๐Ÿ“ Beijing Qilu Pharmaceutical Co., Ltd. ยท Tests: CEND-1, Gemcitabine, Nab paclitaxel Adebrelimab ยฑInduction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC NCT06510660Phase 21 site๐Ÿ“ Fuzhou Fujian Medical University Union Hospital ยท Tests: adebrelimab Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery NCT04891289Phase 211 sites๐Ÿ“ Bethesda๐Ÿ“ St Louis๐Ÿ“ Basking Ridge Memorial Sloan Kettering Cancer Center ยท Tests: Gemcitabine, Oxaliplatin, Dexamethasone, Floxuridine (FUDR), Implanted Medical Device Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC NCT05085496Phase 11 site๐Ÿ“ Duarte City of Hope Medical Center ยท Tests: Atezolizumab, Stereotactic Body Radiation Therapy A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients NCT01638676Phase 1, Phase 21 site๐Ÿ“ Louisville University of Louisville ยท Tests: Vemurafenib, Metformin A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy NCT07633756Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: REC617 A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline) NCT07585266Phase 393 sites๐Ÿ“ Scottsdale๐Ÿ“ San Francisco๐Ÿ“ New Haven GlaxoSmithKline ยท Tests: Velzatinib, Imatinib A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors NCT07165067Phase 13 sites๐Ÿ“ Waratah๐Ÿ“ Brisbane๐Ÿ“ Melbourne AP Biosciences Inc. ยท Tests: AP601 Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC NCT05608200Phase 31 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Lenvatinib, sintilimab plus TACE, Lenvatinib plus TACE Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma NCT07627698Phase 1, Phase 21 site๐Ÿ“ Shenzhen Beijing Biotech ยท Tests: EB-DTKN-401 allogeneic dual-target CSPG4/GD2 CAR-NK cells, Fludarabine, Cyclophosphamide Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment NCT07238881Phase 21 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Dalpiciclib Isetionate Tablets, Dalpiciclib Isetionate Tablets, Camrelizumab (anti-PD-1 inhibitor) Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma NCT07126509NA1 site๐Ÿ“ Chicago University of Chicago ยท Tests: Partial Pleurectomy Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study NCT06849193n/a2 sites๐Ÿ“ Nanjing๐Ÿ“ Nanjing Zhongda Hospital ยท Tests: Systemic chemotherapy combined with immunotherapy Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma NCT07780838Phase 21 site๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab, Gemcitabine Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma NCT07413354Phase 21 site๐Ÿ“ Wuhan Tongji Hospital ยท Tests: Tislelizumab plus Huaier granule Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer NCT06222879Phase 1, Phase 21 site๐Ÿ“ Changsha Shandong Suncadia Medicine Co., Ltd. ยท Tests: HRS-8080; SHR-A1811, HRS-8080; SHR-A2009, SHR-A2009; SHR-1316 A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement NCT07359820Phase 219 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Tampa Elevar Therapeutics ยท Tests: Lirafugratinib SBRT-LATTICE-PATHY NCT07645261Phase 21 site๐Ÿ“ Sรฃo Paulo University of Sao Paulo General Hospital ยท Tests: SBRT-LATTICE-PATHY Liver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research NCT05398380NA1 site๐Ÿ“ Barcelona Hospital Vall d'Hebron ยท Tests: Liver transplantation Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer NCT06179303Phase 23 sites๐Ÿ“ St Louis๐Ÿ“ Chapel Hill๐Ÿ“ Seattle University of Washington ยท Tests: Abemaciclib, Anastrozole, Biospecimen Collection, Computed Tomography, Diagnostic Imaging Testing Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer NCT06173986Phase 1, Phase 21 site๐Ÿ“ Shanghai Shanghai Chest Hospital ยท Tests: PD-1inhibitor, nab-paclitaxel + cisplatin, Radiotherapy First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) NCT06730373Phase 220 sites๐Ÿ“ Zhengzhou๐Ÿ“ Binzhou๐Ÿ“ Dongying Qilu Hospital of Shandong University ยท Tests: Disitamab Vedotin, Sintilimab, S-1, Trastuzumab, Oxaliplatin Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer NCT07194005Phase 21 site๐Ÿ“ Shanghai Fudan University ยท Tests: Disitamab vedotin(RC48), Sintilimab, S-1, Oxaliplatin Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer NCT06984562NA1 site๐Ÿ“ Philadelphia Fox Chase Cancer Center ยท Tests: Adaptive Radiation Therapy
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy